Cognitive Function and Neuroprotection Research
Preclinical investigation of compounds studied for neuroprotective activity, BDNF induction, and cognitive endpoint modulation in murine ischemia and memory research models.
Research Overview
Cognitive function and neuroprotection research examines peptide compounds studied in preclinical models of neurological injury, ischemic damage, and age-related cognitive decline. The primary research systems are rodent stroke and ischemia models, murine spatial memory paradigms (Morris water maze, Barnes maze), and neuronal cell culture systems exposed to oxidative, excitotoxic, or hypoxic stress. Semax (an ACTH(4-7)-PGP analog) has been the subject of sustained preclinical investigation by Myasoedov and colleagues at the Institute of Molecular Genetics (Moscow), with published documentation of BDNF mRNA upregulation in rat hippocampal neurons, neuroprotective effects in middle cerebral artery occlusion (MCAO) stroke models in rats, and improved performance on spatial learning tasks in aged rodents compared to vehicle-treated controls. Pinealon research by Khavinson et al. documented direct chromatin interaction in neuronal cell models and neuroprotective effects in oxidative stress paradigms in murine cells. NAD+ precursor research in murine axonal degeneration models (Araki et al., Science, 2004; Wang et al., Cell, 2016) documented that NAD+ availability determines axonal survival rates following injury in both in vitro and in vivo rodent systems.
Key Research Findings
Findings from preclinical in vitro and in vivo model systems. All summaries reference published research models.
BDNF Induction and Neuroprotection in Rat Stroke Models
Myasoedov and colleagues documented elevated BDNF mRNA and protein levels in rat hippocampal and cortical tissue following Semax administration in Wistar rats, with immunohistochemistry and qPCR data showing 1.5 to 3-fold BDNF upregulation in Semax-treated animals compared to vehicle controls. In MCAO stroke models in Sprague-Dawley rats, Semax-treated animals showed reduced infarct volume, better neurological deficit scores, and reduced inflammatory cytokine levels in brain tissue compared to vehicle-treated controls.
Spatial Memory Improvement in Aged Murine Models
Preclinical studies using the Morris water maze and radial arm maze in aged Wistar rats and C57BL/6 mice documented improved spatial learning acquisition and probe trial performance in Semax-treated animals compared to age-matched vehicle-treated controls, with effect sizes comparable to positive control compounds at matched time points. Separate Pinealon studies by the Khavinson group documented improved memory task performance and reduced oxidative stress markers in aged murine subjects treated with Pinealon compared to saline controls.
Axonal Protection via NAD+ Signaling in Murine Injury Models
Wang et al. (Cell, 2016) documented that SARM1-driven NAD+ depletion is the executioner mechanism of axonal degeneration in murine sciatic nerve injury models, and that maintaining NAD+ levels via NMN administration protected axons from Wallerian degeneration in C57BL/6 mice at 7 days post-injury compared to vehicle controls. The Araki et al. (Science, 2004) study had previously shown that Wld(S) mice, which have constitutively elevated NAD+ in axons, exhibit dramatically delayed Wallerian degeneration in severed optic and sciatic nerve preparations.
Epigenetic Neuroprotection by Pineal Peptides in Cell Models
Khavinson et al. documented that Pinealon (EDR tripeptide) penetrated nuclear membranes and interacted directly with chromatin in isolated neuronal cell preparations, modulating gene expression associated with antioxidant defense and neuronal survival pathways. In oxidative stress cell models using hydrogen peroxide challenge, Pinealon-pre-treated neuronal cultures showed reduced caspase-3 activation and greater cell viability compared to untreated stressed controls in multiple experiments published by the Khavinson group between 2008 and 2018.
Compounds Studied in This Area
Research compounds with documented preclinical activity in this domain.
Broader Research Context
Neuroprotection research spans multiple preclinical disciplines from acute CNS injury models to chronic neurodegeneration paradigms. The Semax literature is concentrated in Russian-language and Eastern European neuropharmacology research groups, with a substantial body of work by Myasoedov, Grivennikov, and colleagues at the Institute of Molecular Genetics published in peer-reviewed neuroscience journals. The NAD+ neuroprotection literature has been advanced primarily by North American and European research groups including Bhatt, Bhattacharya, and Bhattacharya, with the axonal degeneration mechanistic work appearing in high-impact journals. Convergent findings from independent research groups in different model systems (stroke, spatial memory, axonal injury, oxidative stress) support the mechanistic basis for peptide-mediated neuroprotection research.
Research Questions
Continue Your Research
Browse all research areas or explore the full Research Library for compound comparisons, study indexes, and use case guides.